Sep 04, 2018
3:2
For every 2 shares held, investors received 3. The price per share adjusted from $12.91 to $8.61.
The split itself did not change the total investment value.
Beijing Beilu Pharmaceutical Co., Ltd. Class A (SZSE:300016) operates in the Pharmaceuticals: major industry.
Beijing Beilu Pharmaceutical Co., Ltd. Class A company overviewBeijing Beilu Pharmaceutical Co., Ltd. Class A's most recent stock split was on September 4, 2018. It was a 3-for-2 forward split, so shareholders received 3 shares for every 2 they held.
Beijing Beilu Pharmaceutical Co., Ltd. Class A (SZSE:300016) has split its stock 4 times: a 3-for-2 split on May 31, 2010, a 3-for-2 split on May 19, 2011, a 2-for-1 split on April 16, 2013, and a 3-for-2 split on September 4, 2018.
Beijing Beilu Pharmaceutical Co., Ltd. Class A has split its stock 4 times. This history records 4 forward splits between May 31, 2010 and September 4, 2018.
A stock split divides each share into more shares and lowers the price per share by the same factor, so the total value of a holding does not change. In Beijing Beilu Pharmaceutical Co., Ltd. Class A's 3-for-2 split on September 4, 2018, every 2 shares became 3 shares.
Beijing Beilu Pharmaceutical Co., Ltd. Class A has not announced a new split in our records. Its most recent split was on September 4, 2018, 8 years ago. Companies announce splits in advance, and any new SZSE:300016 split will appear on this page.
Already premium?